Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 12 04:00PM ET
3.32
Dollar change
+0.23
Percentage change
7.44
%
Index- P/E- EPS (ttm)-0.39 Insider Own5.03% Shs Outstand31.15M Perf Week-1.19%
Market Cap106.84M Forward P/E- EPS next Y-0.36 Insider Trans10.18% Shs Float30.56M Perf Month7.44%
Income-12.36M PEG- EPS next Q-0.10 Inst Own17.31% Short Float2.33% Perf Quarter25.76%
Sales0.00M P/S- EPS this Y-25.00% Inst Trans6.48% Short Ratio7.23 Perf Half Y4.40%
Book/sh0.68 P/B4.90 EPS next Y10.00% ROA-49.96% Short Interest0.71M Perf Year-4.05%
Cash/sh0.64 P/C5.15 EPS next 5Y- ROE-52.28% 52W Range2.14 - 5.13 Perf YTD-14.43%
Dividend Est.- P/FCF- EPS past 5Y16.79% ROI-56.23% 52W High-35.28% Beta0.88
Dividend TTM- Quick Ratio11.31 Sales past 5Y-55.51% Gross Margin77.14% 52W Low54.78% ATR (14)0.21
Dividend Ex-Date- Current Ratio11.31 EPS Y/Y TTM-13.84% Oper. Margin0.00% RSI (14)55.42 Volatility6.87% 6.40%
Employees5 Debt/Eq0.01 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price8.50
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-26.02% Payout- Rel Volume0.31 Prev Close3.09
Sales Surprise- EPS Surprise9.09% Sales Q/Q- EarningsJun 07 Avg Volume98.47K Price3.32
SMA203.01% SMA509.53% SMA200-0.67% Trades Volume30,332 Change7.44%
Date Action Analyst Rating Change Price Target Change
Dec-23-22Initiated Chardan Capital Markets Buy $8
Apr-12-21Initiated H.C. Wainwright Buy $11
Sep-03-24 08:30AM
Aug-26-24 08:30AM
Jul-29-24 08:45AM
Jul-23-24 08:15AM
07:45AM
08:00AM Loading…
Jul-17-24 08:00AM
Jul-15-24 08:30AM
08:00AM
Jun-24-24 08:45AM
Jun-04-24 09:52PM
May-28-24 06:10AM
May-21-24 07:30AM
May-09-24 04:21AM
May-08-24 08:25AM
May-07-24 09:15AM
08:05AM Loading…
May-06-24 08:05AM
Apr-30-24 07:45AM
Apr-18-24 08:20AM
Mar-14-24 08:45AM
Mar-11-24 08:00AM
Feb-12-24 07:30AM
Jan-29-24 08:50AM
Jan-23-24 07:55AM
Jan-16-24 08:47AM
Jan-10-24 09:00AM
Dec-14-23 07:15AM
Dec-11-23 12:26PM
Dec-06-23 06:00PM
04:05PM
Nov-27-23 08:30AM
08:30AM Loading…
Oct-31-23 08:30AM
Oct-30-23 07:38AM
Oct-23-23 08:30AM
Oct-20-23 05:36AM
Oct-13-23 09:55AM
08:30AM
Oct-12-23 11:08AM
Oct-03-23 08:30AM
Sep-21-23 12:00PM
Sep-19-23 08:30AM
Sep-11-23 10:11PM
Aug-31-23 08:30AM
Aug-28-23 08:30AM
Aug-14-23 08:30AM
Aug-10-23 09:30AM
Aug-07-23 08:30AM
Jul-27-23 08:30AM
Jul-24-23 10:44AM
Jul-21-23 12:05PM
Jul-14-23 10:56AM
Jul-13-23 07:08AM
Jul-11-23 10:24AM
08:30AM
Jul-07-23 10:42AM
Jun-22-23 12:00PM
May-22-23 08:30AM
Apr-25-23 09:40AM
Apr-18-23 11:43AM
Apr-17-23 03:27PM
01:35PM
Apr-14-23 08:50AM
Apr-03-23 08:47AM
Mar-27-23 08:30AM
Mar-13-23 08:30AM
Mar-02-23 08:30AM
Feb-27-23 08:30AM
Feb-21-23 08:30AM
Jan-24-23 07:59AM
Dec-28-22 10:39AM
06:11AM
Dec-19-22 08:30AM
Dec-08-22 08:30AM
Nov-08-22 08:30AM
Oct-31-22 08:30AM
Oct-26-22 08:30AM
Oct-25-22 07:51AM
Oct-10-22 08:30AM
Sep-12-22 08:30AM
Aug-31-22 08:30AM
Aug-15-22 08:30AM
Jul-21-22 08:30AM
Jun-21-22 08:30AM
May-18-22 06:16AM
May-05-22 08:30AM
May-02-22 09:40AM
Apr-28-22 08:30AM
Apr-06-22 08:30AM
Mar-30-22 12:45PM
Mar-17-22 08:30AM
Jan-25-22 08:30AM
Jan-24-22 08:30AM
Dec-16-21 08:30AM
Dec-09-21 04:38AM
Dec-08-21 07:47AM
Dec-07-21 08:30AM
Oct-26-21 08:35AM
Oct-06-21 08:30AM
Oct-01-21 08:30AM
Sep-27-21 02:01PM
Sep-14-21 08:31AM
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, and Other. The CAR-T Therapeutics segment involves the development of immuno-therapy drugs against cancer. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Titterton Lewis H jrDirectorJul 30 '24Buy3.0621,64666,237890,754Aug 01 12:42 PM
Titterton Lewis H jrDirectorJul 31 '24Buy3.235,58018,023896,334Aug 01 12:42 PM
Titterton Lewis H jrDirectorJul 26 '24Buy3.037,70023,331869,108Jul 29 06:05 AM
Titterton Lewis H jrDirectorJul 25 '24Buy2.817962,237861,408Jul 29 06:05 AM
Baskies Arnold MDirectorJul 26 '24Buy3.095,00015,450115,000Jul 26 01:26 PM
Titterton Lewis H jrDirectorJun 14 '24Buy2.684,00010,720860,612Jun 18 09:22 AM
Titterton Lewis H jrDirectorJun 13 '24Buy2.704051,094856,612Jun 14 09:56 AM
Titterton Lewis H jrDirectorJun 11 '24Buy2.667,10218,891856,207Jun 12 11:18 AM
Titterton Lewis H jrDirectorJun 10 '24Buy2.60330858849,105Jun 12 11:18 AM
Titterton Lewis H jrDirectorJun 07 '24Buy2.5210,73827,060848,775Jun 10 10:03 AM
Catelani MichaelPresident, COO, & CFOJun 07 '24Buy2.406,25015,00035,211Jun 07 12:24 PM
KUMAR AMITChief Executive OfficerJun 07 '24Buy2.4125,00060,250516,925Jun 07 10:57 AM
Titterton Lewis H jrDirectorApr 09 '24Buy3.2815,00949,230838,037Apr 10 09:44 AM
Baskies Arnold MDirectorMar 15 '24Buy3.6310,00036,300110,000Mar 15 02:15 PM
KUMAR AMITChief Executive OfficerMar 15 '24Buy3.2230,00096,600491,925Mar 15 10:49 AM
Titterton Lewis H jrDirectorOct 10 '23Option Exercise2.5816,00041,200823,028Oct 11 10:35 AM